Guidance for completing applications for a permit to import kava for medical and/or scientific purposes

Guidance note for 'Testing of cannabis and cannabis resin' updated.

The Australian Government response to the Inquiry into current barriers to patient access to medicinal cannabis has now been published

The Australian Government will implement a second phase of the pilot program to increase the amount of kava allowed to be imported in Australia.

This guidance is for stakeholders who are applying for a new licence under the Narcotic Drugs Act 1967 to cultivate, produce and/or manufacture cannabis or cannabis material for the purposes of patient supply or research using downloadable flat forms

Provides information on how the Office of Drug Control implements cost recovery for regulatory activities associated with the direct costs of processing licence and permit applications for the cultivation of medicinal cannabis and the ongoing monitoring and compliance of the regulatory scheme

Further information on medicinal cannabis manufacture licences and permit applications

Guideline to assist licence applicants and holders in designing and meeting standards required for record keeping and reporting matters related to cultivation, production and manufacture of medicinal cannabis

Guidance for completing import/export licence applications for narcotic, psychotropic and precursor substances